Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis
Gabrielle Agin-Liebes, Eve Ekman, B. Anderson, et al.
Journal of Humanistic Psychology (2021) Vol. 64, Iss. 4, pp. 564-591
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world
Rosalind Watts, Hannes Kettner, Dana Geerts, et al.
Psychopharmacology (2022) Vol. 239, Iss. 11, pp. 3461-3483
Open Access | Times Cited: 82
Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
Mauro Cavarra, Alessandra Falzone, Johannes G. Ramaekers, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 65
Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca
Gabrielle Agin-Liebes, Richard J. Zeifman, Jason B. Luoma, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 295-308
Open Access | Times Cited: 38
How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change
Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson, et al.
Journal of Affective Disorders (2023) Vol. 334, pp. 100-112
Open Access | Times Cited: 29
An Integrated theory of false insights and beliefs under psychedelics
H. T. McGovern, Hilary Jane Grimmer, Manoj K. Doss, et al.
Communications Psychology (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Self-treatment with psychedelic substances for health and wellbeing in Aotearoa New Zealand: an exploratory descriptive study
Chris Arnison, Richard Egan, John H. Shaver
Kōtuitui New Zealand Journal of Social Sciences Online (2025), pp. 1-22
Open Access
Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review
Viktoriia Kurkova, Olga Winkler, Andrew J. Greenshaw, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111333-111333
Closed Access
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 660-678
Open Access | Times Cited: 15
Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study
Jacob S. Aday, Emily K. Bloesch, Alan K. Davis, et al.
Journal of Psychoactive Drugs (2024), pp. 1-10
Open Access | Times Cited: 4
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
David B. Yaden, Marianna Graziosi, Anna Owen, et al.
Psychedelic Medicine (2025)
Closed Access
Exploring Serotonergic Psychedelics as a Treatment for Personality Disorders
Brennan M. Carrithers, Daniel E. Roberts, Brandon Weiss, et al.
Neuropharmacology (2025), pp. 110413-110413
Closed Access
Experiences of psilocybin treatment for clinical conditions: A qualitative meta‐synthesis
Marie Crowe, Jenni Manuel, Dave Carlyle, et al.
International Journal of Mental Health Nursing (2023) Vol. 32, Iss. 4, pp. 1025-1037
Open Access | Times Cited: 10
Assessing potential of psilocybin for depressive disorders
Zofia Kozak, Matthew W. Johnson, Scott T. Aaronson
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 10, pp. 887-900
Closed Access | Times Cited: 8
“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use
Meghan DellaCrosse, Mollie Pleet, Emma Morton, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0279073-e0279073
Open Access | Times Cited: 12
Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences
Fiona Low, Mitch Earleywine
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 3, pp. 316-323
Closed Access | Times Cited: 7
An Integrated theory of false insights and beliefs under psychedelics
Hugh McGovern, Hilary Jane Grimmer, Manoj K. Doss, et al.
(2023)
Open Access | Times Cited: 7
Social identity processes as a vehicle for therapeutic success in psychedelic treatment
Martha Newson, S. Alexander Haslam, Catherine Haslam, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1010-1017
Closed Access | Times Cited: 2
‘Mind-Revealing’ Psychedelic States: Psychological Processes in Subjective Experiences That Drive Positive Change
Rúna F. E. Walther, Hein T. van Schie
Psychoactives (2024) Vol. 3, Iss. 3, pp. 411-436
Open Access | Times Cited: 2
Psychedelic-Assisted Psychotherapy and Mindfulness-Based Cognitive Therapy: Potential Synergies
Richard Chambers, Devon Stoliker, Otto Simonsson
Mindfulness (2023) Vol. 14, Iss. 9, pp. 2111-2123
Open Access | Times Cited: 6
Acceptability of psilocybin‐assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis
Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, et al.
Cancer (2023) Vol. 130, Iss. 7, pp. 1147-1157
Closed Access | Times Cited: 5
How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change
Richard J. Zeifman
(2024)
Open Access | Times Cited: 1
The library is open: a scoping review on queer representation in psychedelic research
Amy Bartlett, Challian Christ, Bradford Martins, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
On the mushrooming reports of “quiet quitting”: Employees’ lifetime psilocybin use predicts their overtime hours worked
Benjamin A. Korman
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 4, pp. 475-484
Closed Access | Times Cited: 3
Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis
Noah D. Gold, Austin Mallard, Jacob C. Hermann, et al.
Journal of Palliative Medicine (2023) Vol. 26, Iss. 10, pp. 1408-1418
Closed Access | Times Cited: 2
How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change
Richard J. Zeifman
(2024)
Open Access
Page 1 - Next Page

Scroll to top